Drug Shortage Report for ACTONEL DR

Last updated on 2020-06-19 History
Report ID 117615
Drug Identification Number 02370417
Brand name ACTONEL DR
Common or Proper name risedronate
Company Name ALLERGAN INC
Market Status MARKETED
Active Ingredient(s) RISEDRONATE SODIUM
Strength(s) 35MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL ORAL
Packaging size 4 tabs
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-06-09
Actual start date 2020-06-09
Estimated end date 2020-06-18
Actual end date 2020-06-18
Shortage status Resolved
Updated date 2020-06-19
Company comments
Health Canada comments
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-06-19 English Compare
v6 2020-06-18 French Compare
v5 2020-06-18 English Compare
v4 2020-06-18 French Compare
v3 2020-06-18 English Compare
v2 2020-06-12 French Compare
v1 2020-06-12 English Compare